What is the recommended trigger shot (dose and timing) for a woman undergoing ovulation‑induced intrauterine insemination (IUI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trigger Shot for IUI: Dose and Timing Recommendations

Primary Recommendation

Use hCG 5,000-10,000 IU intramuscularly or subcutaneously as the trigger shot when 1-2 follicles reach ≥15 mm diameter, and perform single IUI 24-40 hours after hCG administration. 1, 2

Trigger Shot Selection and Dosing

Standard hCG Protocol

  • hCG remains the gold standard trigger for IUI cycles, with doses of 5,000-10,000 IU administered intramuscularly or subcutaneously 1, 3, 4
  • The trigger should be administered when the leading follicle reaches ≥17-18 mm mean diameter 3, 4

GnRH Agonist Triggers: Not Recommended

  • Do not use GnRH agonist triggers in IUI cycles despite their theoretical appeal for OHSS prevention 5, 1
  • International guidelines explicitly recommend against GnRH agonists because they provide no increase in pregnancy rates while increasing multiple pregnancy rates and costs 5, 1
  • While older research showed GnRH agonists could salvage high-risk cycles, 26% of patients developed defective luteal phases, making this approach unreliable 6

Optimal IUI Timing After Trigger

Flexible Window Approach

  • Perform single IUI anytime within 24-40 hours after hCG injection without compromising pregnancy rates 1, 2
  • Studies comparing different intervals within this window (24h vs 36h vs 40h) show no statistically significant differences in overall pregnancy rates 2, 4

Etiology-Specific Timing Considerations

  • For unexplained infertility: Earlier timing at 24 hours post-hCG may provide better pregnancy rates compared to 36 hours (though guidelines support the full 24-40h window) 7
  • For male factor infertility: Post-ovulatory timing (closer to 36-40 hours) appears optimal, and double IUI may provide marginal benefit in this specific population 4
  • For PCOS/anovulatory patients: Timing within the 24-40 hour window shows equivalent outcomes 7

Critical Safety Parameters: When to Withhold Trigger

Mandatory Cycle Cancellation Criteria

Cancel the cycle and withhold hCG trigger if any of the following are present: 5, 1

  • More than 2 dominant follicles >15 mm diameter, OR
  • More than 5 follicles >10 mm diameter

Rationale for Strict Cancellation Criteria

  • Multiple pregnancy risk escalates dramatically: 6% with 2 follicles, 14% with 3 follicles, 10% with 4 follicles 5
  • Multiple pregnancies significantly increase maternal morbidity (preterm delivery, pre-eclampsia, growth retardation) and neonatal complications 5
  • Alternative to cancellation: Consider aspiration of excess follicles at time of trigger or conversion to IVF 5, 1

Ovarian Stimulation Protocol to Minimize Risk

Gonadotropin Dosing

  • Use low-dose gonadotropins ≤75 IU per day to minimize multiple pregnancy risk while maintaining pregnancy rates 5, 1
  • Higher gonadotropin doses produce similar pregnancy rates but significantly increase multiple pregnancy rates 5

Alternative Medications

  • Clomiphene citrate (100 mg daily for 5 days) or tamoxifen are acceptable alternatives with lower multiple pregnancy rates and costs, though they produce lower live birth rates than gonadotropins 5, 1
  • Do not add GnRH antagonists to gonadotropin-stimulated IUI cycles, as they provide no pregnancy rate benefit 8

Natural Cycle Alternative

LH Surge Detection Method

  • In natural cycles without ovarian stimulation, perform IUI exactly 1 day after detecting the spontaneous LH surge 2
  • This timing produces equivalent pregnancy rates to hCG-triggered cycles when properly executed 2, 3
  • Avoid using basal body temperature charts for timing, as they do not reliably predict ovulation 2

Common Pitfalls to Avoid

  • Do not perform double IUI: Single insemination is sufficient, as double IUI shows no significant benefit in unexplained or most male factor cases while increasing cost and patient burden 2
  • Do not use GnRH agonists or antagonists as adjuncts in IUI cycles 5, 1, 8
  • Do not proceed with trigger if >2 follicles >15mm or >5 follicles >10mm are present—this is the single most important safety measure to prevent high-order multiple pregnancies 5, 1
  • Apply 10-15 minutes of bed rest after insemination to optimize sperm migration 2

Special Consideration: Ovulatory Dysfunction

  • Women with ovulatory dysfunction (PCOS, anovulation) who receive hCG trigger show significantly higher pregnancy rates (24.6%) compared to women with other infertility etiologies 3
  • For anovulatory patients specifically, hCG administration before insemination is particularly beneficial and should not be omitted 3

References

Guideline

GnRH Agonist Triggers in IUI Cycles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Optimal Timing for Intrauterine Insemination (IUI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.